Inventor · disambiguated record
Tetsuhiko Yoshida
Also filed as: YOSHIDA TETSUHIKO
58 granted patents·19 pending applications·81 citations·filing 1998–2024
97Inventor score
Files withTOAGOSEI CO LTD60YOSHIDA TETSUHIKO6KOBAYASHI NAHOKO2LIGHTRON CO LTD2TOA GOSEI KABUSHIKI KAISHA2
Top patents by PatentIndex Score
77 records- 0194US11313862B2Method for diagnosing amyotrophic lateral sclerosis using signal peptide as indicatorTOAGOSEI CO LTD·Filed 2017·Granted Apr 26, 2022·8 cites·12 claims
- 0291US11927589B2Carrier peptide fragment for nucleolar localization and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Mar 12, 2024·1 cites·8 claims
- 0389US7964556B1Antimicrobial peptides and use thereofTOAGOSEI CO LTD·Filed 2007·Granted Jun 21, 2011·9 cites·3 claims
- 0480US9353350B2Method for producing multipolar cellTOAGOSEI CO LTD·Filed 2012·Granted May 31, 2016·2 cites·8 claims
- 0578US11230586B2Exosome production methodTOAGOSEI CO LTD·Filed 2020·Granted Jan 25, 2022·1 cites·7 claims
- 0678US10100284B2Method for inducing differentiation of pluripotent stem cells into endodermal cellsTOAGOSEI CO LTD·Filed 2014·Granted Oct 16, 2018·2 cites·8 claims
- 0777US2025129368A1siRNA based on RNA sequence of SARS-CoV-2 and use thereofTOAGOSEI CO LTD·Filed 2024·Application pending·0 cites
- 0876US11965011B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Apr 23, 2024·0 cites·8 claims
- 0976US9353351B2Method for producing multipolar cellTOAGOSEI CO LTD·Filed 2012·Granted May 31, 2016·2 cites·8 claims
- 1076US6862532B2Apparatus for manifesting latent characteristics existing in sequences of symbolsTOA GOSEI KABUSHIKI KAISHA·Filed 2002·Granted Mar 1, 2005·4 cites·20 claims
- 1175US8822408B2Cell growth-promoting peptide and use thereofYOSHIDA TETSUHIKO·Filed 2011·Granted Sep 2, 2014·3 cites·4 claims
- 1275US7482328B2Antimicrobial polypeptide and utilization thereofTOAGOSEI CO LTD·Filed 2003·Granted Jan 27, 2009·11 cites·4 claims
- 1374US11299555B2Method for diagnosing alzheimer's disease using signal peptide as indicatorTOAGOSEI CO LTD·Filed 2017·Granted Apr 12, 2022·1 cites·3 claims
- 1473US9296787B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2012·Granted Mar 29, 2016·2 cites·2 claims
- 1572US9309307B2Antibody against amyloid precursor protein signal peptideFUKUSHIMA HITOSHI·Filed 2012·Granted Apr 12, 2016·2 cites·1 claims
- 1671US10046022B2Synthetic peptide that increases radiosensitivity of tumor cells and use of sameTOAGOSEI CO LTD·Filed 2016·Granted Aug 14, 2018·1 cites·12 claims
- 1771US9029513B2Anti-EGFR antibody and use thereofSHIMIZU NOBUYOSHI·Filed 2011·Granted May 12, 2015·1 cites·9 claims
- 1870US12209242B2siRNA based on RNA sequence of SARS-CoV-2 and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Jan 28, 2025·0 cites·3 claims
- 1970US11505589B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2019·Granted Nov 22, 2022·0 cites·2 claims
- 2069US10112977B2Peptide for inducing multinucleation in cells, and use thereforTOAGOSEI CO LTD·Filed 2015·Granted Oct 30, 2018·1 cites·9 claims
- 2169US9480727B2Synthetic peptide for inhibiting expression of type 2 TNF receptor and use thereofTOAGOSEI CO LTD·Filed 2013·Granted Nov 1, 2016·1 cites·6 claims
- 2268US2024182577A1Anti-pd-1 signal peptide antibody and use thereofTOAGOSEI CO LTD·Filed 2024·Application pending·0 cites
- 2367US12285476B2Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibodyTOAGOSEI CO LTD·Filed 2022·Granted Apr 29, 2025·0 cites·6 claims
- 2467US7674771B2Antimicrobial peptides and utilization of the sameTOAGOSEI CO LTD·Filed 2004·Granted Mar 9, 2010·4 cites·4 claims
- 2566US11814448B2Carrier peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2021·Granted Nov 14, 2023·0 cites·6 claims
- 2666US8603967B2Carrier peptide fragment and use thereofYOSHIDA TETSUHIKO·Filed 2010·Granted Dec 10, 2013·1 cites·5 claims
- 2765US12392770B2Foreign substance introduction construct and use thereofTOAGOSEI CO LTD·Filed 2023·Granted Aug 19, 2025·0 cites·9 claims
- 2865US2025262333A1Construct for Transferring Foreign Substance, and Use ThereofTOAGOSEI CO LTD·Filed 2023·Application pending·0 cites
- 2965US2025382331A1Carrier Peptide Fragment and Use ThereofTOAGOSEI CO LTD·Filed 2023·Application pending·0 cites
- 3063US11767345B2Antiviral peptide and use thereofTOAGOSEI CO LTD·Filed 2021·Granted Sep 26, 2023·0 cites·2 claims
- 3163US9365618B2Synthetic peptide that induces expression of TNF receptor 2 and use thereofKOBAYASHI NAHOKO·Filed 2012·Granted Jun 14, 2016·1 cites·4 claims
- 3262US11780903B2Peptide suppressing binding of CTLA4 to B7 proteins, and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·3 claims
- 3361US9370182B2Antimicrobial peptide and use thereofTOAGOSEI CO LTD·Filed 2013·Granted Jun 21, 2016·0 cites·3 claims
- 3461US2006122122A1Antimicrobial peptides and use thereofTOAGOSEI CO LTD·Filed 2005·Application pending·0 cites
- 3560US2024262863A1Peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2022·Application pending·0 cites
- 3660US2022089641A1Carrier Peptide Fragment and Use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 3758US11603395B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Mar 14, 2023·0 cites·8 claims
- 3858US2022008547A1Carrier Peptide Fragment and use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 3957US2023399368A1Carrier peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 4057US2023272005A1Amino Acid Sequence Derived from Sars-Cov-2 and Use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 4156US11352408B2Antitumor peptide having PD-1 signal sequence and utilization thereofTOAGOSEI CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·3 claims
- 4256US11155582B2Antiviral peptide and use thereofTOAGOSEI CO LTD·Filed 2019·Granted Oct 26, 2021·0 cites·13 claims
- 4356US6438496B1Method and apparatus for revealing latent characteristics existing in symbolic sequencesTOA GOSEI KABUSHIKI KAISHA·Filed 1998·Granted Aug 20, 2002·22 cites·31 claims
- 4455US10981953B2Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulinTOAGOSEI CO LTD·Filed 2014·Granted Apr 20, 2021·0 cites·11 claims
- 4554US7893031B2Neuronal differentiation inhibitor peptide and use thereofTOAGOSEI CO LTD·Filed 2006·Granted Feb 22, 2011·0 cites·2 claims
- 4653US11285195B2Pharmaceutical composition for inhibiting expression of CD47 in tumor cells and use of sameTOAGOSEI CO LTD·Filed 2018·Granted Mar 29, 2022·0 cites·6 claims
- 4753US2009030179A1Antimicrobial peptide and use thereofTOAGOSEI CO LTD·Filed 2006·Application pending·0 cites
- 4852US9133437B2Cell proliferation-promoting peptide and use thereofTOAGOSEI CO LTD·Filed 2014·Granted Sep 15, 2015·0 cites·8 claims
- 4952US2010297758A1Artificial peptide and use thereofTOAGOSEI CO LTD·Filed 2009·Application pending·0 cites
- 5051US11472845B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·8 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tetsuhiko Yoshida files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →